(202) 599-8435

FDA Issues Final Guidance for Evaluating Generic Opioids with Abuse-Deterrent Properties

Posted on Dec 01, 2017
By :

On Nov. 21, the U.S. Food and Drug Administration (FDA) issued final industry guidance for developing generic opioids with abuse-deterrent properties. According to FDA Commissioner Scott Gottlieb, M.D., the industry guidance is an effort at “transitioning from the current market, dominated by conventional opioids, to one in which most opioids have abuse-deterrent properties.” Read more here.

Print Friendly, PDF & Email
About the Author